AN2 Therapeutics News - ANTX

Company Name	Stock Ticker Symbol	Market	Type
AN2 Therapeutics Inc	ANTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.0069	-0.28%	2.4931	14:39:24

Open Price	Low Price	High Price	Close Price	Prev Close
2.51	2.43	2.55		2.50

more quote information »

Recent News

Date	Time	Source	Heading
4/16/2024	8:52	IHNW	FeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
3/28/2024	16:10	BW	AN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
2/13/2024	17:11	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/12/2024	07:01	EDGAR2	Form 8-K - Current report
2/12/2024	06:45	BW	AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
1/30/2024	16:10	BW	AN2 Therapeutics to Present at Oppenheimer Healthcare Life..
1/18/2024	18:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	17:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/12/2024	17:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/11/2024	19:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	18:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/04/2024	18:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	16:45	EDGAR2	Form 144 - Report of proposed sale of securities
1/02/2024	16:36	EDGAR2	Form 144 - Report of proposed sale of securities
11/16/2023	18:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/09/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:10	EDGAR2	Form 8-K - Current report
11/09/2023	16:05	BW	AN2 Therapeutics Reports Third Quarter 2023 Financial..
11/06/2023	07:00	BW	AN2 Therapeutics to Present at Upcoming Investor Conferences
10/18/2023	07:00	BW	AN2 Therapeutics Signs License Agreement with the University..
10/11/2023	00:01	BW	AN2 Therapeutics to Present New Data for Epetraborole at..
10/03/2023	19:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/02/2023	16:10	EDGAR2	Form 144 - Report of proposed sale of securities
9/29/2023	17:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/29/2023	16:11	EDGAR2	Form 144 - Report of proposed sale of securities
9/26/2023	07:00	BW	AN2 Therapeutics Signs Grant Agreement to Discover Novel,..
9/15/2023	17:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	08:00	EDGAR2	Form 8-K - Current report
9/13/2023	07:00	BW	AN2 Therapeutics commences Phase 3 Part of Phase 2/3..
9/08/2023	16:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/23/2023	16:14	EDGAR2	Form 144 - Report of proposed sale of securities
8/16/2023	16:50	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/16/2023	16:47	EDGAR2	Form 8-K - Current report
8/15/2023	22:42	BW	AN2 Therapeutics Announces Pricing of $70.0 Million..
8/10/2023	16:25	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:18	EDGAR2	Form 8-K - Current report
8/10/2023	16:10	BW	AN2 Therapeutics Reports Second Quarter 2023 Financial..
5/25/2023	16:10	BW	AN2 Therapeutics to Present at Jefferies Healthcare..
5/11/2023	16:10	BW	AN2 Therapeutics Reports First Quarter 2023 Financial..
5/01/2023	07:00	BW	AN2 Therapeutics to Present at JMP Securities Life Sciences..